{
     "PMID": "1654266",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19911022",
     "LR": "20151119",
     "IS": "0014-2999 (Print) 0014-2999 (Linking)",
     "VI": "207",
     "IP": "3",
     "DP": "1991 Jul 12",
     "TI": "Chloroamphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate cyclase in rat hippocampus.",
     "PG": "209-13",
     "AB": "Administration of p-chloroamphetamine (PCA, 10 mg/kg i.p. on two occasions) to rats resulted in a severe depletion of [3H]paroxetine binding sites, a measure of presynaptic serotonergic terminals, in both cortex and hippocampus, but did not affect [3H]8-hydroxy-2-(di-n-propylamino)tetralin [( 3H]8-OH-DPAT) binding or 5-hydroxytryptamine (5-HT)-induced inhibition of forskolin-stimulated adenylate cyclase in hippocampal membranes. Administration of either imipramine (15 mg/kg i.p. for 2 weeks) or lithium (0.2% for 2 weeks) to PCA-treated rats did not affect [3H]8-OH-DPAT binding but reduced the degree of inhibition of forskolin-stimulated adenylate cyclase by 5-HT in hippocampal membranes. It is concluded that the effects of imipramine and Li+ on 5-HT1A receptor-mediated responses in the hippocampus are exerted postsynaptically, possibly at a level distal to the receptor.",
     "FAU": [
          "Newman, M E",
          "Ben-Zeev, A",
          "Lerer, B"
     ],
     "AU": [
          "Newman ME",
          "Ben-Zeev A",
          "Lerer B"
     ],
     "AD": "Ya'acov Herzog Center for Brain and Psychiatry Research, Ezrath Nashim Hospital, Jerusalem, Israel.",
     "LA": [
          "eng"
     ],
     "GR": [
          "MH 43873/MH/NIMH NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "Netherlands",
     "TA": "Eur J Pharmacol",
     "JT": "European journal of pharmacology",
     "JID": "1254354",
     "RN": [
          "0 (Adenylyl Cyclase Inhibitors)",
          "0 (Antidepressive Agents)",
          "0 (Chlorides)",
          "0 (Piperidines)",
          "0 (Tetrahydronaphthalenes)",
          "1F7A44V6OU (Colforsin)",
          "333DO1RDJY (Serotonin)",
          "41VRH5220H (Paroxetine)",
          "64-12-0 (p-Chloroamphetamine)",
          "78950-78-4 (8-Hydroxy-2-(di-n-propylamino)tetralin)",
          "9FN79X2M3F (Lithium)",
          "EC 4.6.1.1 (Adenylyl Cyclases)",
          "G4962QA067 (Lithium Chloride)",
          "OGG85SX4E4 (Imipramine)"
     ],
     "SB": "IM",
     "MH": [
          "8-Hydroxy-2-(di-n-propylamino)tetralin",
          "*Adenylyl Cyclase Inhibitors",
          "Adenylyl Cyclases/metabolism",
          "Animals",
          "Antidepressive Agents/*pharmacology",
          "Binding Sites",
          "Cerebral Cortex/drug effects/metabolism",
          "Chlorides/pharmacology",
          "Colforsin/*pharmacology",
          "Hippocampus/*drug effects/enzymology/metabolism",
          "Imipramine/pharmacology",
          "Lithium/pharmacology",
          "Lithium Chloride",
          "Male",
          "Paroxetine",
          "Piperidines/metabolism",
          "Rats",
          "Serotonin/*pharmacology",
          "Synapses/drug effects/metabolism",
          "Tetrahydronaphthalenes/metabolism",
          "p-Chloroamphetamine/*pharmacology"
     ],
     "EDAT": "1991/07/12 00:00",
     "MHDA": "1991/07/12 00:01",
     "CRDT": [
          "1991/07/12 00:00"
     ],
     "PHST": [
          "1991/07/12 00:00 [pubmed]",
          "1991/07/12 00:01 [medline]",
          "1991/07/12 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharmacol. 1991 Jul 12;207(3):209-13.",
     "term": "hippocampus"
}